Advertisement
Advertisement
November 20, 2026
Haemonetics’ Vascade MVP XL Venous Vascular Closure System Receives CE Mark
KEY TAKEAWAYS
- Haemonetics received CE Mark certification under the EU Medical Device Regulation for its Vascade MVP XL venous vascular closure system.
- The device is indicated for femoral venous access closure after procedures using 10- to 12-F sheaths with a maximum outer diameter of 15 F.
- Initial European procedures using the system were performed in October 2026 at centers in Germany, Italy, and the United Kingdom.
November 20, 2026—Haemonetics Corporation announced CE Mark certification for the Vascade MVP XL venous vascular closure system under the EU-MDR (European Medical Device Regulation) for the percutaneous closure of femoral venous access sites. The device will be available in the European Union and other geographies that recognize CE Mark.
Haemonetics advised that the new system provides a robust closure solution for procedures requiring 10-F to 12-F sheaths (up to 15-F outer diameter) such as cryoablation or pulsed field ablation procedures and left atrial appendage closure. The Vascade MVP XL uses 58% more collagen and a 9% larger disc than the Vascade MVP system, noted the press release.
The device is intended to reduce time to ambulation, total postprocedure time, time to hemostasis, and time to discharge eligibility compared to conventional closure methods. Additionally, it enables same-day discharge in patients who have undergone catheter-based procedures using 10-F to 12-F inner diameters (15-F maximum outer diameter) procedural sheaths, with single or multiple access sites in one or both limbs.
According to the company, the first European procedures with the Vascade MVP XL system were performed in October by Professor Christian H. Heeger, MD, Director Department of Rhythmology at Asklepios Clinic Altona in Hamburg, Germany; Professor Claudio Tondo, MD, at Centro Cardiologico Monzino, IRCCS, in Milan, Italy; and Riyaz A. Kaba, MD, at Cromwell Hospital in London, United Kingdom.
Prof. Heeger commented in the Haemonetics press release, “The Vascade MVP system has become an important part of our approach to post-procedure care, helping us shorten time to ambulation and facilitate earlier discharge for appropriate patients. With the Vascade MVP XL system, we can now apply the same closure technology more confidently in procedures requiring larger venous access within the approved indication.”
Advertisement
Advertisement